MedPath

Comparison of different mouth rinse for oral ulcer in head & neck cancer patients

Phase 3
Conditions
Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Registration Number
CTRI/2020/01/022824
Lead Sponsor
Vardhman Mahavir Medical College and Safdarjung Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Head and neck cancer patients with oral mucositis ( World Health Organization grade 1-4)

Exclusion Criteria

. Patients with severe renal or hepatic insufficiency

. Patients with collagen vascular disorder

. Patients allergy to any ingredient of the mouth rinse

. Pregnancy

. Patients with active oral infection requiring antibiotics/antifungals

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analgesic efficacy in terms of improvement in pain scores and doses of analgesicsTimepoint: 1st day, 3rd day, 1st, 2nd, 3rd and 4th week
Secondary Outcome Measures
NameTimeMethod
different side effectsTimepoint: 1st day, 3rd day, 1st, 2nd, 3rd and 4th week;Duration of pain relief following the use of different mouth rinseTimepoint: duration 30 minutes, 30 mins-1 hr or 1 hr;ECOG scoreTimepoint: 1st day, 3rd day, 1st, 2nd, 3rd and 4th week;Functional impairment scale(FIS)Timepoint: 1st day, 3rd day, 1st, 2nd, 3rd and 4th week;Patient satisfaction scoresTimepoint: 4th week;WHO grading of mucositisTimepoint: 1st day, 3rd day, 1st, 2nd, 3rd and 4th week
© Copyright 2025. All Rights Reserved by MedPath